Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin
The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Abstract
Engineered Salmonella secreting heterologous bacterial flagellin suppress tumor growth by activating intratumoral macrophages.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with intratumoral or intravenous injection often leading to ~10,000-fold accumulation in tumors relative to matched liver, spleen, and lung tissues (152, 153).”
From The microbiome and human cancer (2021) · cites this paper as [152]
Citations
Cites
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828 · cited 1×
“INTRODUCTION Abnormal blood vessels and hypoxic and necrotic regions are universal features of solid tumors (1, 2).”
BackgroundKigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., & Popovich, P. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3257-09.2009 · Cited by 2,130 · cited 1×
“The engrafted MC38 tumor tissues were removed from C57BL/6 WT mice 24 hours after induction of FlaB and triple-stained with CD45, F4/80, and CD206 (to detect M2-type macrophages) or with CD45, F4/80, and CD86 (to detect M1-type macrophages) (32, 33).”
MethodTargeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041 · cited 1×
“TLR4, TLR5, and MyD88 knockout mice with a C57BL/6 genetic background were described previously (47, 48).”
MethodMolecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance
Wang, N., Liang, H., & Zen, K. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00614 · Cited by 1,980 · cited 10×
“The in vitro stimulation of cancer cells with FlaB did not increase phosphorylation of NF-kB p65 (fig.”
BackgroundInfluentialThe Isolation and Characterization of Murine Macrophages
Zhang, X., Goncalves, R., & Mosser, D. M. (2008) · Current Protocols in Immunology · doi:10.1002/0471142735.im1401s83 · Cited by 1,536 · cited 1×
“Cell preparation and FACS analysis Peritoneal macrophages were isolated from specific pathogen–free C57BL/6 male mice, as described previously (50).”
MethodToll-like receptors and cancer
Rakoff-Nahoum, S., & Medzhitov, R. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2541 · Cited by 925
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
Saito, T., Nishikawa, H., Wada, H., Nagano, Y., Sugiyama, D., Atarashi, K., Maeda, Y., Hamaguchi, M., Ohkura, N., Sato, E., et al. (2016) · Nature Medicine · doi:10.1038/nm.4086 · Cited by 871 · cited 1×
“Because the background signals in experimental groupswere different, whichmay be due to different degrees of cell injury resulting from the different modes of treatment (PBS, empty Salmonella, and FlaB-secreting Salmonella), we adjusted gating parameters for the FACS analysis of different groups (51, 52).”
MethodTherapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007) · Nature Medicine · doi:10.1038/nm1589 · Cited by 869 · cited 1×
“Because of accumulating reports that activating various TLRs resulted in antitumor effects (31, 37–41), many TLRspecific agonists are currently being investigated for tumor immunotherapy (37).”
BackgroundBiswas, S. K. (2006) · Blood · doi:10.1182/blood-2005-01-0428 · Cited by 696
Toso, J. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.142 · Cited by 614 · cited 1×
“VNP20009, an attenuated strainof Salmonella typhimurium with purI and msbB gene deletions, was safely administered to patients with metastatic melanoma and renal cell carcinoma in a phase 1 study, where substantial tumor colonization was observed (11, 12).”
Zhao, M., Yang, M., Li, X.-M., Jiang, P., Baranov, E., Li, S., Xu, M., Penman, S., & Hoffman, R. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408422102 · Cited by 484 · cited 1×
“These hypoxic and anoxic microenvironments may be targeted by obligatory or facultative anaerobic bacteria, such as Bifidobacterium (3), Salmonella (4, 5), Escherichia (6, 7), Clostridium (8), and Listeria (9).”
BackgroundUematsu, S., Jang, M. H., Chevrier, N., Guo, Z., Kumagai, Y., Yamamoto, M., Kato, H., Sougawa, N., Matsui, H., Kuwata, H., et al. (2006) · Nature Immunology · doi:10.1038/ni1362 · Cited by 450 · cited 1×
“TLR4, TLR5, and MyD88 knockout mice with a C57BL/6 genetic background were described previously (47, 48).”
MethodThe intriguing role of polymorphonuclear neutrophils in antitumor reactions
Di Carlo, E., Forni, G., Lollini, P., Colombo, M. P., Modesti, A., & Musiani, P. (2001) · Blood · doi:10.1182/blood.v97.2.339 · Cited by 419 · cited 1×
“These activated effector cells should be able to kill tumor cells by producing cytotoxic mediators, including reactive oxygen species, NO, proteases, membrane-perforating agents, and cytokines (27, 28, 36).”
BackgroundTsuji, S., Matsumoto, M., Takeuchi, O., Akira, S., Azuma, I., Hayashi, A., Toyoshima, K., & Seya, T. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.6883-6890.2000 · Cited by 409
Intratumoral injection of Clostridium novyi -NT spores induces antitumor responses
Roberts, N. J., Zhang, L., Janku, F., Collins, A., Bai, R.-Y., Staedtke, V., Rusk, A. W., Tung, D., Miller, M., Roix, J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008982 · Cited by 400
Clairmont, C., Lee, K. C., Pike, J., Ittensohn, M., Low, K. B., Pawelek, J., Bermudes, D., Brecher, S. M., Margitich, D., Turnier, J., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315497 · Cited by 355
Bacteria-mediated delivery of nanoparticles and cargo into cells
Akin, D., Sturgis, J., Ragheb, K., Sherman, D., Burkholder, K., Robinson, J. P., Bhunia, A. K., Mohammed, S., & Bashir, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.149 · Cited by 347
M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7
Xiao, X., Gaffar, I., Guo, P., Wiersch, J., Fischbach, S., Peirish, L., Song, Z., El-Gohary, Y., Prasadan, K., Shiota, C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321347111 · Cited by 312 · cited 1×
“The engrafted MC38 tumor tissues were removed from C57BL/6 WT mice 24 hours after induction of FlaB and triple-stained with CD45, F4/80, and CD206 (to detect M2-type macrophages) or with CD45, F4/80, and CD86 (to detect M1-type macrophages) (32, 33).”
MethodZhao, M., Yang, M., Ma, H., Li, X., Tan, X., Li, S., Yang, Z., & Hoffman, R. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0716 · Cited by 305
De Filippo, K., Henderson, R. B., Laschinger, M., & Hogg, N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.4308 · Cited by 294 · cited 1×
“For example, TLR4 signaling by tissue macrophages or tumor cells induces production of chemokines that promote recruitment of neutrophils (40) or immature DCs (38, 39) to tumors.”
BackgroundCharacterization of the Erwinia carotovora pelB gene and its product pectate lyase
Lei, S. P., Lin, H. C., Wang, S. S., Callaway, J., & Wilcox, G. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.9.4379-4383.1987 · Cited by 285 · cited 1×
“9, eaak9537 (2017) 8 February 2017 expression was tightly regulated by L-arabinose and that the protein was successfully secreted from the bacteria that were guided by the pelB leader sequence, as observed previously (30).”
MethodIn Situ Regulation of DC Subsets and T Cells Mediates Tumor Regression in Mice
Ali, O. A., Emerich, D., Dranoff, G., & Mooney, D. J. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000359 · Cited by 246
Zhao, M., Geller, J., Ma, H., Yang, M., Penman, S., & Hoffman, R. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703867104 · Cited by 244
Functional gene transfer from intracellular bacteria to mammalian cells
Grillot-Courvalin, C., Goussard, S., Huetz, F., Ojcius, D. M., & Courvalin, P. (1998) · Nature Biotechnology · doi:10.1038/nbt0998-862 · Cited by 230
Jiang, S.-N., Phan, T. X., Nam, T.-K., Nguyen, V. H., Kim, H.-S., Bom, H.-S., Choy, H. E., Hong, Y., & Min, J.-J. (2010) · Molecular Therapy · doi:10.1038/mt.2009.295 · Cited by 226 · cited 4×
“These hypoxic and anoxic microenvironments may be targeted by obligatory or facultative anaerobic bacteria, such as Bifidobacterium (3), Salmonella (4, 5), Escherichia (6, 7), Clostridium (8), and Listeria (9).”
BackgroundMethodInfluentialSelf-citationLee, S. E., Kim, S. Y., Jeong, B. C., Kim, Y. R., Bae, S. J., Ahn, O. S., Lee, J.-J., Song, H.-C., Kim, J. M., Choy, H. E., et al. (2006) · Infection and Immunity · doi:10.1128/iai.74.1.694-702.2006 · Cited by 226
Self-citationCai, Z., Sanchez, A., Shi, Z., Zhang, T., Liu, M., & Zhang, D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1993 · Cited by 214 · cited 4×
“Evaluation of TLR5 expression in cancer cells and macrophages FlaB acts via TLR5, which is expressed on the surface of various cells (31).”
BackgroundResultInfluentialGenetically Engineered Salmonella typhimurium as an Imageable Therapeutic Probe for Cancer
Nguyen, V. H., Kim, H.-S., Ha, J.-M., Hong, Y., Choy, H. E., & Min, J.-J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3453 · Cited by 214
Self-citationSalmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β
Kim, J.-E., Phan, T. X., Nguyen, V. H., Dinh-Vu, H.-V., Zheng, J. H., Yun, M., Park, S.-G., Hong, Y., Choy, H. E., Szardenings, M., et al. (2015) · Theranostics · doi:10.7150/thno.11432 · Cited by 200
Self-citationAntitumor Activity of the TLR-5 Ligand Flagellin in Mouse Models of Cancer
Sfondrini, L., Rossini, A., Besusso, D., Merlo, A., Tagliabue, E., Mènard, S., & Balsari, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6624 · Cited by 194 · cited 1×
“Bacterial flagellin is the natural ligand for TLR5, and reports indicate that activation of the TLR5 signaling pathway by flagellin induces antitumor activity in several experimental animal models (26, 31, 44).”
BackgroundNishikawa, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28045 · Cited by 183 · cited 1×
“Different strategies have been used to deliver therapeutic agents, such as cytotoxic proteins (5, 7, 18), cytokines (20), antigens, and antibodies (21), or genetic materials, such as short hairpin RNA (22), to tumor tissues using engineered Salmonella.”
MethodAttenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth
Loeffler, M., Le'Negrate, G., Krajewska, M., & Reed, J. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701959104 · Cited by 180 · cited 3×
“Although these strategies resulted in improved therapeutic effects, they still have limitations; for example, multiple injections of bacteria are required, and tumors tend to recur (20, 23, 24).”
BackgroundQuantitative bioluminescence imaging of tumor-targeting bacteria in living animals
Min, J.-J., Nguyen, V. H., Kim, H.-J., Hong, Y., & Choy, H. E. (2008) · Nature Protocols · doi:10.1038/nprot.2008.32 · Cited by 170
Self-citationCharacterization of HCT116 Human Colon Cancer Cells in an Orthotopic Model
Rajput, A., Dominguez San Martin, I., Rose, R., Beko, A., LeVea, C., Sharratt, E., Mazurchuk, R., Hoffman, R. M., Brattain, M. G., & Wang, J. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2007.04.021 · Cited by 167
Engineering of Bacteria for the Visualization of Targeted Delivery of a Cytolytic Anticancer Agent
Jiang, S.-N., Park, S.-H., Lee, H. J., Zheng, J. H., Kim, H.-S., Bom, H.-S., Hong, Y., Szardenings, M., Shin, M. G., Kim, S.-C., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.183 · Cited by 153
Self-citationppGpp-dependent Stationary Phase Induction of Genes on Salmonella Pathogenicity Island 1
Song, M., Kim, H.-J., Kim, E. Y., Shin, M., Lee, H. C., Hong, Y., Rhee, J. H., Yoon, H., Ryu, S., Lim, S., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313491200 · Cited by 145
Self-citationYam, C., Zhao, M. D., Hayashi, K., Ma, H., Kishimoto, H., McElroy, M. K., Bouvet, M., & Hoffman, R. M. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.02.023 · Cited by 138
IL-18-producing Salmonella inhibit tumor growth
Loeffler, M., Le'Negrate, G., Krajewska, M., & Reed, J. C. (2008) · Cancer Gene Therapy · doi:10.1038/cgt.2008.48 · Cited by 133 · cited 4×
“Although these strategies resulted in improved therapeutic effects, they still have limitations; for example, multiple injections of bacteria are required, and tumors tend to recur (20, 23, 24).”
BackgroundMethodInfluentialImmune response induced by Salmonella typhimurium defective in ppGpp synthesis
Na, H. S., Kim, H. J., Lee, H., Hong, Y., Rhee, J. H., & Choy, H. E. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.11.031 · Cited by 123
Self-citationSalmonella typhimurium engineered to produce CCL21 inhibit tumor growth
Loeffler, M. W., Le'Negrate, G., Krajewska, M., & Reed, J. C. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0555-9 · Cited by 121 · cited 3×
“Although these strategies resulted in improved therapeutic effects, they still have limitations; for example, multiple injections of bacteria are required, and tumors tend to recur (20, 23, 24).”
BackgroundActivation of inflammasome by attenuated Salmonella typhimurium in bacteria‐mediated cancer therapy
Phan, T. X., Nguyen, V. H., Duong, M. T., Hong, Y., Choy, H. E., & Min, J. (2015) · Microbiology and Immunology · doi:10.1111/1348-0421.12333 · Cited by 115 · cited 3×
“These activated effector cells should be able to kill tumor cells by producing cytotoxic mediators, including reactive oxygen species, NO, proteases, membrane-perforating agents, and cytokines (27, 28, 36).”
BackgroundSelf-citationYano, S., Zhang, Y., Zhao, M., Hiroshima, Y., Miwa, S., Uehara, F., Kishimoto, H., Tazawa, H., Bouvet, M., Fujiwara, T., et al. (2014) · Cell Cycle · doi:10.4161/15384101.2014.964115 · Cited by 106 · cited 1×
“Another mutant strain, A1-R, inhibited the growth of various tumors in mouse models (13–15) and forced quiescent cells to enter the cell cycle, thereby making them sensitive to chemotherapy (16).”
BackgroundNguyen, C. T., Hong, S. H., Sin, J., Vu, H. V. D., Jeong, K., Cho, K. O., Uematsu, S., Akira, S., Lee, S. E., & Rhee, J. H. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.06.054 · Cited by 92
Self-citationZhu, H., Li, Z., Mao, S., Ma, B., Zhou, S., Deng, L., Liu, T., Cui, D., Zhao, Y., He, J., et al. (2011) · Cancer Gene Therapy · doi:10.1038/cgt.2011.57 · Cited by 90 · cited 2×
“He, C. Yi, Y. Huang, Antitumor effect of sFlt-1 gene therapy system mediated by Bifidobacterium Infantis on Lewis lung cancer in mice.”
BackgroundToll-like Receptor 4 Mediates an Antitumor Host Response Induced by Salmonella choleraesuis
Lee, C.-H., Wu, C.-L., & Shiau, A.-L. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2050 · Cited by 89
Jeong, J.-H., Kim, K., Lim, D., Jeong, K., Hong, Y., Nguyen, V. H., Kim, T.-H., Ryu, S., Lim, J.-A., Kim, J. I., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0080050 · Cited by 79
Self-citationSalmonella and cancer: from pathogens to therapeutics.
Chorobik, P., Czaplicki, D., Ossysek, K., & Bereta, J. (2013) · Acta Biochimica Polonica · doi:10.18388/abp.2013_1984 · Cited by 68
Lee, C., Wu, C., & Shiau, A. (2008) · International Journal of Cancer · doi:10.1002/ijc.23047 · Cited by 66
Hypoxia induces a phase transition within a kinase signaling network in cancer cells
Wei, W., Shi, Q., Remacle, F., Qin, L., Shackelford, D. B., Shin, Y. S., Mischel, P. S., Levine, R. D., & Heath, J. R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303060110 · Cited by 64 · cited 1×
“INTRODUCTION Abnormal blood vessels and hypoxic and necrotic regions are universal features of solid tumors (1, 2).”
BackgroundEngineering and Visualization of Bacteria for Targeting Infarcted Myocardium
Le, U. N., Kim, H.-S., Kwon, J., Kim, M. Y., Nguyen, V. H., Jiang, S. N., Lee, B.-I., Hong, Y., Shin, M., Rhee, J. H., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.25 · Cited by 46
Self-citationWang, L., Liu, Q., Sun, Q., Zhang, C., Chen, T., & Cao, X. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.12.030 · Cited by 43 · cited 2×
“For example, TLR4 signaling by tissue macrophages or tumor cells induces production of chemokines that promote recruitment of neutrophils (40) or immature DCs (38, 39) to tumors.”
BackgroundZhang, G., & Yang, Y. (2008) · Journal of Combinatorial Optimization · doi:10.1007/s10878-008-9199-0 · Cited by 32
TLR5 takes aim at bacterial propeller
Reichhart, J. (2003) · Nature Immunology · doi:10.1038/ni1203-1159 · Cited by 27 · cited 1×
“Because flagellinmonomers bind toTLR5 (45), endogenous”
Research works printed but not linked: 1
- 10.1200/jco.2002.20.1.142 · DOI · Paper page
Cited by
Molecular principles of metastasis: a hallmark of cancer revisited
Fares, J., Fares, M. Y., Khachfe, H. H., Salhab, H. A., & Fares, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0134-x · Cited by 2,379
The microbiome and human cancer
Sepich-Poore, G. D., Zitvogel, L., Straussman, R., Hasty, J., Wargo, J. A., & Knight, R. (2021) · Science · doi:10.1126/science.abc4552 · Cited by 1,332
“5B), with intratumoral or intravenous injection often leading to ~10,000-fold accumulation in tumors relative to matched liver, spleen, and lung tissues (152, 153).”
BackgroundThe microbiome, cancer, and cancer therapy
Helmink, B. A., Khan, M. A. W., Hermann, A., Gopalakrishnan, V., & Wargo, J. A. (2019) · Nature Medicine · doi:10.1038/s41591-019-0377-7 · Cited by 1,200
Progress in tumor-associated macrophage (TAM)-targeted therapeutics
Ngambenjawong, C., Gustafson, H. H., & Pun, S. H. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.010 · Cited by 840
“reported development of a dual TLR4/5 stimulating bacterial cell therapy (BCT) based on attenuated ΔppGpp Salmonella typhimurium (TLR4 agonist) with inducible production of Vibrio vulnificus flagellin B (FlaB, TLR5 agonist) [167].”
Tumour-targeting bacteria engineered to fight cancer
Zhou, S., Gravekamp, C., Bermudes, D., & Liu, K. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0070-z · Cited by 821
Metadata
- Authors
- Zheng, J. H., Nguyen, V. H., Jiang, S.-N., Park, S.-H., Tan, W., Hong, S. H., Shin, M. G., Chung, I.-J., Hong, Y., Bom, H.-S., Choy, H. E., Lee, S. E., Rhee, J. H., & Min, J.-J.
- Affiliations
- Chonnam National University (KR)
- City Of Hope National Medical Center (US)
- Department of Nuclear Medicine, Chonnam National University Medical School, Gwangju 61469, Republic of Korea.
- Korea Research Institute of Bioscience and Biotechnology (KR)
- Corresponding author
- Rhee, Joon Haeng
- Min, Jung-Joon
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2017-02-08
- Volume
- 9
- Issue
- 376
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2586223583
- Cited by
- 588
- References
- 54
- Citations by year
- 2026: 76 · 2025: 81 · 2024: 85 · 2023: 73 · 2022: 71 · 2021: 65 · 2020: 55 · 2019: 34 · 2018: 30 · 2017: 18
- FWCI
- 27.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- KRIBB Repository (submittedVersion)
- Funders
- Pioneer Research Center Program (2015M3C1A3056410)
- Bio & Medical Technology Development Program (NRF-2014M3A9B5073747)
- National Research Foundation of Korea
- Ministry of Science, ICT and Future Planning
- NRF (2012-0006072)
- Ministry of Health and Welfare, Republic of Korea (HI14C0187)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- cancer immunotherapy, Salmonella typhimurium, tumor-targeting bacteria, intratumoral macrophages, M1 macrophage polarization, TLR ligands
- MeSH terms
- Animals, Colonic Neoplasms, Flagellin, Genetic Engineering, Humans, Immunotherapy, Macrophages, Male, Mice, Inbred C57BL, Mice, Nude, Neoplasm Metastasis, Neoplasms, Phenotype, Salmonella typhimurium, Colony Count, Microbial, Signal Transduction, Cell Polarity, Xenograft Model Antitumor Assays, HCT116 Cells, Toll-Like Receptor 5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.